PRVA - Privia Health Group Inc. (PRVA) Q1 2024 Earnings Call Transcript
2024-05-11 10:35:24 ET
Privia Health Group, Inc. (PRVA)
Q1 2024 Earnings Conference Call
May 9, 2024 8:00 AM ET
Company Participants
Robert Borchert – Senior Vice President-Investor and Corporate Communications
Parth Mehrotra – Chief Executive Officer
David Mountcastle – Chief Financial Officer
Conference Call Participants
A.J. Rice – UBS
Sameer Patel – Evercore ISI
Joshua Raskin – Nephron Research
David Larsen – BTIG
Richard Close – Canaccord Genuity
Andrew Mok – Barclays
Jeff Garro – Stephens
Jack Slevin – Jefferies
Jess Tassan – Piper Sandler
Ryan Daniels – William Blair
Whit Mayo – Leerink Partners
Jailendra Singh – Truist
Daniel Grosslight – Citi
Adam Ron – Bank of America
Presentation
Operator
Welcome to the Privia Health First Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker, Robert Borchert, SVP of Investor and Corporate Communications. Please go ahead.
Robert Borchert
Thank you, Tana, and good morning, everyone. Joining me are Parth Mehrotra, our Chief Executive Officer; and David Mountcastle, our Chief Financial Officer. This call is being webcast, can be accessed in the Investor Relations section of priviahealth.com. Today's financial press release and slide presentation are posted on the Investor Relations pages of priviahealth.com. Following our prepared comments, we will open the line for questions. We ask that you please limit yourself to one question only, and return to the queue if you have a follow-up, so we can get to as many questions as possible.
The financial results reported today are preliminary and are not final until our Form 10-Q for the first quarter ended March 31, 2024, is filed with the Securities and Exchange Commission. Some of the statements we will make today are forward-looking in nature based on our current expectations and view of our business as of May 9, 2024.
Such statements, including those related to our future financial and operating performance and future business plans and objectives are subject to risks and uncertainties that may cause actual results to differ materially. As a result, these statements should be considered along with the cautionary statements in today's press release and the risk factors described in our company's most recent SEC filings.
Finally, we may refer to certain non-GAAP financial measures on the call. Reconciliation of these measures to comparable GAAP measures are included in our press release and the accompanying slide presentation posted on our website....
Privia Health Group, Inc. (PRVA) Q1 2024 Earnings Call Transcript